Painreform is trading at $1.03 (+5.28%) after the regular session closed on September 24, 2026, with the catalyst still unclear.

  • Searches found no verified earnings release, regulatory decision, acquisition, or other company-specific announcement dated September 24, 2026; major U.S. indexes ended lower.
  • The latest identifiable filings were earlier in September, and prior sector-driven strength does not directly explain the after-hours move.
  • Monitor for delayed filings or late-breaking news.